- KATHLEEN MAHER
- Nada Rashid
Project ECHO® (Extension for Community Healthcare Outcomes) is a statewide educational, teleECHO initiative that connects clinical experts with primary care providers and medication assisted treatment prescribers across Wisconsin in an effort to reduce substance-related complications. Via a regularly scheduled videoconference, a multidisciplinary panel of specialists provide education and lead a collaborative discussion on submitted patient cases. This effort is sponsored by UW Department of Family Medicine and Community Health and the Wisconsin Department of Health Services, Division of Care and Treatment Services. Funding for this project was made possible by grant 435200-G-18-11448-285932-880 from the Substance Abuse and Mental Health Services Administration. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official polices of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Sign-up to receive email notifications regarding upcoming sessions: https://www.fammed.wisc.edu/echo/alerts/
For more information visit our webpage: https://www.fammed.wisc.edu/echo/
Target Audience: Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Pharmacy Technicians, Psychologists, Social Workers, Patient/Caregivers, Students
|Randy Brown, MD PhD, Chair||Nada Rashid, Coordinator|
|Sheila Weix, MSN, RN, CARN||Ritu Bhatnagar, DO|
|Lindsey Peterson, MS, CRC||Paul Hutson, PharmD|
|Susan Mindock, LPC, CSAC||Richard Crawford, MD|
|In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Department of Health Services, Division of Care and Treatment Services. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1 hour of knowledge-based CE credit. Credit can be earned by successfully completing this live activity. Pharmacists and Pharmacy Technicians should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
Pharmacists and Pharmacy Technicians must enter their NABP number in their profile in order to receive credit.
2020 Universal Activity Number (UAN) JA0000358-9999-20-141-L01-P
2021 Universal Activity Number (UAN) JA0000358-9999-21-065-L01-P
2022 Universal Activity Number (UAN)
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series participant will increase their ability to:
- Implement appropriate opioid prescribing and monitoring practices.
- Effectively participate in office-based, collaborative management of substance use disorders.
- Consistently provide in overdose prevention education to appropriate patients.
- Identify the role of medication assisted therapies, such as methadone, naltrexone, and buprenorphine, and contributions of different members of the healthcare team to the management of substance use disorders.